Sarcoma Treatment Market 2020 Global Size, Share, Growth Opportunities, Comprehensive Analysis, Competitive Landscape, Future Prospects with Regional Trends by Forecast 2027
Global Sarcoma Treatment Market – Competitive Landscape
Key players operating in the sarcoma treatment market include Novartis International AG, Eli Lilly and Company, Amgen Inc., Johnson & Johnson, Johnson & Johnson, Bayer AG, Epizyme, Inc., Tyme Technologies, Inc., and others.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/3537
Sarcoma is a type of cancer, which occurs in connective tissues. Moreover, sarcoma is broadly classified into two types such as soft tissue sarcoma and bone sarcoma. Soft tissue sarcomas occur in tissues of blood vessels, nerves, tendons, muscles, fat, and lining of the joints. Soft tissue sarcomas are mostly found in legs, arms, abdomen, and chest. There are over 50 types of soft tissue sarcoma. Soft tissue sarcoma symptoms include lump growth, abdominal pain, blood in stools, and vomiting.
Bone sarcomas mostly occur in the long bones in arms and legs, and the pelvic bones. Symptoms of bone sarcoma include fatigue, weaken bone leading to frequent fractures, bone pain, and swelling and tenderness near the affected area. On the basis of severity of cancer, sarcomas are divided into four stages, which include Stage 1 to Stage 4. Sarcomas are treated through chemotherapies, radiation therapies, targeted therapies, and surgeries.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3537
Global Sarcoma Treatment Market – Dynamics
Key players are focusing on enhancing their product portfolio through product launches and new product approvals for sarcoma treatment, which is expected to boost sarcoma treatment market growth over the forecast period. For instance, in January 2020, Epizyme, Inc., received the U.S. Food and Drug Administration (FDA) approval for Tazverik, a target specific drug indicated for the treatment of epithelioid sarcoma in patients of age 16 and above.
Furthermore, players operating in the market are focused on research for development of new and efficient treatment for sarcoma, which is expected to propel growth of the market over the forecast period. For instance, in October 2019, Tyme Technologies, Inc. initiated HopES, a phase 2 clinical trial, to evaluate safety and efficacy of SM-88, a monotherapy for clinically advanced sarcomas. The trial is expected to complete in the year 2022.
Need a discount?
Note: *The discount is offered on the Standard Price of the report.
Request discount for this report @ https://www.coherentmarketinsights.com/insight/request-discount/3537
Global Sarcoma Treatment Market – Regional Insights
North America accounted for the largest market share in 2018. This is attributed to rising incidences of sarcomas in the region. For instance, the American Cancer Society has estimated that in 2020, around 13,130 new cases of soft tissue sarcomas will be diagnosed in the U.S. Furthermore, in 2018, the American Cancer Society reported that rhabdomyosarcoma accounts for around 3% cases of pediatric cancers in the U.S.
Europe is expected to be the second-largest market in global sarcoma treatment market and it is expected to witness significant growth over the forecast period, owing to increasing number of sarcoma incidences in the region. For instance, in July 2018, Sarcoma UK, a national cancer charity, reported that over 5,300 cases of sarcomas are diagnosed every year in the U.K.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/sarcoma-treatment-market-3537
Global Sarcoma Treatment Market – Taxonomy
On the basis of sarcoma type, global sarcoma treatment market is segmented into:
- Soft Tissue Sarcoma
- Bone Sarcoma
- Ewing Sarcoma
On the basis of treatment type, global sarcoma treatment market is segmented into:
- Targeted Therapy
On the basis of end users, global sarcoma treatment market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
On the basis of region, global sarcoma treatment market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Other Exclusive Reports:
Proton Therapy Market, By Set up Type (Single Room, Multiple Room), By Indication (Head & Neck Cancer, Brain Cancer, Sarcoma, Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027
Sarcoma Biopsy Market, by Product Type (Reusable Device and Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire